1: Sato K, Hayashi T, Ishizaki T, Yoshida M, Watanabe A. Disseminated Lomentospora prolificans infection that could have been predicted: A case report. IDCases. 2024 Jul 31;37:e02046. doi: 10.1016/j.idcr.2024.e02046. PMID: 39188368; PMCID: PMC11347068.
2: D J S, Annapureddy KKR, Poojary N, Balapanga S, Kumari B. Mucormycosis in an Immunocompetent Patient Recovering From Dengue Fever. Cureus. 2024 Jul 23;16(7):e65212. doi: 10.7759/cureus.65212. PMID: 39176311; PMCID: PMC11340907.
3: Jäger MC, González-Ruiz V, Joos FL, Winter DV, Boccard J, Degenhardt T, Brand S, Rudaz S, Thompson GR 3rd, Odermatt A. Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids. Front Pharmacol. 2024 Aug 8;15:1394846. doi: 10.3389/fphar.2024.1394846. PMID: 39175536; PMCID: PMC11338861.
4: Ogawa L, Multani A, Beaird OE, Gaynor P, Carlson M, Garner OB, Schiller G, Schaenman JM. Risk Factors and Outcomes of Mucorales Infection in a Modern Cohort of Solid Organ Transplant, Hematopoietic Cell Transplant, and Chimeric Antigen Receptor T-cell Therapy Recipients. Transplant Proc. 2024 Aug 21:S0041-1345(24)00433-0. doi: 10.1016/j.transproceed.2024.07.005. Epub ahead of print. PMID: 39174391.
5: Ali W, Agarwal M, Jamal S, Gangwar R, Sharma R, Mubarak MM, Wani ZA, Ahmad Z, Khan A, Sheikh JA, Grover A, Bhaskar A, Dwivedi VP, Grover S. Revitalizing antimicrobial strategies: paromomycin and dicoumarol repurposed as potent inhibitors of M.tb's replication machinery via targeting the vital protein DnaN. Int J Biol Macromol. 2024 Aug 22;278(Pt 3):134652. doi: 10.1016/j.ijbiomac.2024.134652. Epub ahead of print. PMID: 39173789.
6: Ngo D, Tinajero J, Zhang J, Stein A, Marcucci G, Salhotra A, Pullarkat V, Sandhu KS, Ball BJ, Pourhassan H, Koller P. Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia. J Oncol Pharm Pract. 2024 Aug 16:10781552241276547. doi: 10.1177/10781552241276547. Epub ahead of print. PMID: 39150342.
7: Lai CC, Hsueh PR. Chronic pulmonary aspergillosis in Taiwan: Disease burden, diagnosis, treatment, and outcomes. J Microbiol Immunol Infect. 2024 Aug 2:S1684-1182(24)00124-5. doi: 10.1016/j.jmii.2024.07.013. Epub ahead of print. PMID: 39142908.
8: Allen S. Recurrent Mucor indicus central venous catheter infection in a five year old child on long term parenteral nutrition for short gut syndrome: could gut translocation be responsible? Med Mycol Case Rep. 2024 Jul 14;45:100661. doi: 10.1016/j.mmcr.2024.100661. PMID: 39139261; PMCID: PMC11321366.
9: Zhumatayev S, Celen SS, Kara M, Selcuk AA, Bozkurt B, Demir MK, Yalcın K. Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis. Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3552-3555. doi: 10.1007/s12070-024-04610-1. Epub 2024 Apr 4. PMID: 39130341; PMCID: PMC11306456.
10: Yun J, Wang Z, Liu W. Voriconazole-induced central nervous system toxicity: a pharmacovigilance study based on FDA adverse event reporting system (FAERS) database. Expert Opin Drug Saf. 2024 Aug 19:1-8. doi: 10.1080/14740338.2024.2391492. Epub ahead of print. PMID: 39129467.
11: Gupta AK, Wang T, Mann A, Polla Ravi S, Talukder M, Lincoln SA, Foreman HC, Kaplan B, Galili E, Piguet V, Shemer A, Bakotic WL. Antifungal resistance in dermatophytes - review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections. Expert Rev Anti Infect Ther. 2024 Aug 18:1-13. doi: 10.1080/14787210.2024.2390629. Epub ahead of print. PMID: 39114868.
12: Cabanilla MG, Shald EA, Hlavacek NL, Bernauer ML, Sosa NR. Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults. IDCases. 2024 Jul 3;37:e02024. doi: 10.1016/j.idcr.2024.e02024. PMID: 39114643; PMCID: PMC11305272.
13: Halliday CL, Tay E, Green W, Law D, Lopez R, Faris S, Meehan L, Harvey E, Birch M, Chen SCA. In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020-2023. J Antimicrob Chemother. 2024 Aug 6:dkae267. doi: 10.1093/jac/dkae267. Epub ahead of print. PMID: 39105545.
14: Wang J, Liu L, Li J, Feng X, Yi H, Jiang E, Zheng Y, Zhang F, Zhu X, Mi Y, Han M, Wang J, Feng S. Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases. Mycopathologia. 2024 Aug 1;189(4):71. doi: 10.1007/s11046-024-00875-w. PMID: 39088077.
15: Kondori N, Jaén-Luchoro D, Karlsson R, Abedzaedeh B, Hammarström H, Jönsson B. Exophiala species in household environments and their antifungal resistance profile. Sci Rep. 2024 Jul 31;14(1):17622. doi: 10.1038/s41598-024-68166-4. PMID: 39085337; PMCID: PMC11291800.
16: Cao J, Pan P, Feng D, Wang M, Zheng Y, Yang N, Chen X, Zhai W, Zhang R, Ma Q, Wei J, Yang D, He Y, Wang X, Feng S, Han M, Jiang E, Pang A. Posaconazole gastro-resistant tablets for preventing invasive fungal disease after haematopoietic stem cell transplantation: a propensity-matched cohort study. Clin Microbiol Infect. 2024 Jul 26:S1198-743X(24)00351-3. doi: 10.1016/j.cmi.2024.07.019. Epub ahead of print. PMID: 39067514.
17: Mehta P, Ngo D, Tinajero J. Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. J Oncol Pharm Pract. 2024 Jul 25:10781552241265884. doi: 10.1177/10781552241265884. Epub ahead of print. PMID: 39052976.
18: Kim U, Perzia B, Kulkarni P, Rajiniganth M, Sundar B, Robin AL, Garg Shukla A, Maeng MM. COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients. Orbit. 2024 Jul 25:1-10. doi: 10.1080/01676830.2024.2377249. Epub ahead of print. PMID: 39051497.
19: Rathee A, Solanki P, Emad NA, Zai I, Ahmad S, Alam S, Alqahtani AS, Noman OM, Kohli K, Sultana Y. Posaconazole-hemp seed oil loaded nanomicelles for invasive fungal disease. Sci Rep. 2024 Jul 18;14(1):16588. doi: 10.1038/s41598-024-66074-1. PMID: 39025925; PMCID: PMC11258229.
20: Borchardt-Setter KA, Yu J, Stelzer T, Yu L. Surface Enrichment and Depletion of Components in a Ternary Drug-Surfactant-Polymer Amorphous Solid Dispersion. Mol Pharm. 2024 Aug 5;21(8):4074-4081. doi: 10.1021/acs.molpharmaceut.4c00444. Epub 2024 Jul 15. PMID: 39008633.